Detalles de la búsqueda
1.
Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valvesã- Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry.
Circ J
; 86(3): 440-448, 2022 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719560
2.
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patientsã- A Subanalysis of the ENVISAGE-TAVI AF Trial.
Circ J
; 86(11): 1756-1763, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965066
3.
Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve.
Circ J
; 86(11): 1699-1707, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35811134
4.
Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study.
Cardiovasc Drugs Ther
; 34(5): 689-696, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710129
5.
Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study.
J Cardiol
; 76(1): 44-50, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32156512
6.
Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Virus Res
; 155(1): 48-54, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20801174
7.
Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences.
Clin Cancer Res
; 17(9): 2807-18, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21346145
Resultados
1 -
7
de 7
1
Próxima >
>>